L. Ford

B. Kramer, I. Thompson, L. Ford, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Chin, I. Thompson, P. Goodman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Chin, I. Thompson, P. Goodman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishing a Primary Care Alliance for Conducting Cancer Prevention Clinical Research at Community Sites

W. McCaskill-Stevens, L. Ford, B. McAneny, 2021, Cancer Prevention Research.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Michael M Lieber, J Michael Gaziano, Ian M Thompson, 2005, Journal of the National Cancer Institute.

Phase III prostate cancer chemoprevention trials.

H. Parnes, L. Minasian, L. Ford, 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

The influence of finasteride on the development of prostate cancer.

Michael M Lieber, Ian M Thompson, Scott M Lippman, 2003, The New England journal of medicine.

The prostate cancer prevention trial: design, biases and interpretation of study results.

J. Crowley, I. Thompson, P. Goodman, 2006, The Journal of urology.

Estrogen replacement therapy in breast cancer survivors.

L. Ford, J. Perlman, S. Nayfield, 1995, JAMA.

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors.

Kisha I Coa, L. Minasian, L. Ford, 2019, The American journal of medicine.

Implementation of the Prostate Cancer Prevention Trial (PCPT).

J. Crowley, I. Thompson, P. Goodman, 2004, Controlled clinical trials.

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

N. Cook, J. Cuzick, P. Brown, 2015 .

Predictive Value Tools as an Aid in Chemopreventive Agent Development.

B. Kramer, V. Steele, D. Ransohoff, 2013, Journal of the National Cancer Institute.

Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer.

S. Reis, W. McCaskill-Stevens, L. Ford, 2015 .

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Norman Wolmark, Scott M Lippman, S. Reis, 2006, JAMA.

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs.

L. Ford, G. Samimi, E. Szabo, 2022, Cancer prevention research.

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

K. Gadde, P. Prorok, L. Ford, 2021, Diabetes Care.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

Joseph P. Costantino, V. Craig Jordan, Victor G. Vogel, 2010, Cancer Prevention Research.

Design of the Prostate Cancer Prevention Trial (PCPT).

J. Crowley, B. Kramer, I. Thompson, 1995, Controlled clinical trials.

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

A. LaCroix, S. Cummings, J. Cuzick, 2013, The Lancet.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

J. Crowley, I. Thompson, P. Goodman, 2009, JAMA.

Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank

B. Kramer, W. McCaskill-Stevens, L. Ford, 2016, Cancer Prevention Research.

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

L. Ford, J. Zell, L. M. Rodriguez, 2019, Cancer Prevention Research.

Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience.

B. Kramer, L. Ford, B. Dunn, 1998, Hematology/oncology clinics of North America.

Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders

L. Ford, E. Szabo, B. Dunn, 2014, Cancer Prevention Research.

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

Suzanne G. Orchard, P. Gibbs, J. McNeil, 2021, Cancers.

From Adjuvant Therapy to Breast Cancer Prevention: BCPT and STAR

L. Ford, B. Dunn, 2001, The breast journal.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

L. Ford, J. Costantino, D. Wickerham, 2005, Journal of the National Cancer Institute.

Prevention of hormone-related cancers: prostate cancer.

I. Thompson, H. Parnes, L. Ford, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention and Early Detection Clinical Trials: Opportunities for Primary Care Providers and Their Patients

W. McCaskill-Stevens, E. Pisano, L. Minasian, 2003, CA: a cancer journal for clinicians.

Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

Suzanne G. Orchard, C. Reid, J. McNeil, 2020, Journal of the National Cancer Institute.

Both Light Intensity and Moderate‐to‐Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study

J. Manson, A. LaCroix, C. Kooperberg, 2017, Journal of the American Heart Association.

Rare loss of function variants in candidate genes and risk of colorectal cancer

Taylor J. Maxwell, Jennifer G. Robinson, Andrew J. Sanford, 2018, Human Genetics.

Hormonal interventions to prevent hormonal cancers: breast and prostate cancers

L. Ford, B. Dunn, 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Repurposing metformin for the prevention of cancer and cancer recurrence

L. Ford, A. Decensi, B. Heckman-Stoddard, 2017, Diabetologia.

Estimates of benefits and harms of prophylactic use of aspirin in the general population

N. Cook, J. Cuzick, P. Brown, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.

L. Ford, B. Dunn, A. Ryan, 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

J. Manson, A. LaCroix, R. Langer, 2006, JAMA.

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

P. Brown, L. Minasian, L. Ford, 2019, Cancer Prevention Research.

Factors Associated With New‐Onset Depression Following Ischemic Stroke: The Women's Health Initiative

J. Manson, A. LaCroix, C. Kooperberg, 2017, Journal of the American Heart Association.

Prevention of hormone-related cancers: breast cancer.

L. Ford, D. Wickerham, B. Dunn, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Nutrient Approach to Prostate Cancer Prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

L. Minasian, L. Ford, B. Dunn, 2010, Nutrition and cancer.

Long-term survival of participants in the prostate cancer prevention trial.

Ian M Thompson, Lori M Minasian, I. Thompson, 2013, The New England journal of medicine.

EFFECT OF INITIATING ASPIRIN ON CANCER EVENTS IN THE HEALTHY ELDERLY

P. Gibbs, J. McNeil, L. Ford, 2019, Innovation in Aging.

400a – Effect of Initiating Aspirin on Cancer Events in the Healthy Elderly: Primary Results from the Aspree Randomized Controlled Trial

P. Gibbs, J. McNeil, L. Ford, 2019, Gastroenterology.

The potential for hormonal prevention trials

B. Kramer, L. Ford, O. Brawley, 1994, Cancer.

Breast cancer prevention trials: large and small trials.

L. Ford, B. Arun, B. Dunn, 2010, Seminars in oncology.

Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial

Jennifer G. Robinson, J. Manson, A. LaCroix, 2017, Journal of the American Heart Association.

Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention

I. Thompson, P. Goodman, M. Lucia, 2008, Cancer Prevention Research.

Exemestane for breast cancer prevention: a critical shift?

L. Ford, B. Dunn, A. Decensi, 2012, Cancer discovery.

Breast cancer prevention: the next steps.

W. McCaskill-Stevens, L. Ford, B. Dunn, 2000, European journal of cancer.

Change in Physical Activity and Sitting Time After Myocardial Infarction and Mortality Among Postmenopausal Women in the Women's Health Initiative‐Observational Study

Andrea K. Chomistek, J. Manson, A. LaCroix, 2017, Journal of the American Heart Association.

The use of tamoxifen and raloxifene for the prevention of breast cancer.

L. Ford, J. Costantino, D. Wickerham, 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Estimating Rates of True High-Grade Disease in the Prostate Cancer Prevention Trial

H. Parnes, L. Ford, P. Pinsky, 2008, Cancer Prevention Research.

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

C K Redmond, B Fisher, C. Redmond, 1999, Journal of the National Cancer Institute.

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

T. Walsh, M. King, L. Ford, 2001, JAMA.

Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.

E. Trimble, L. Ford, S. Green, 1996, Journal of the National Cancer Institute.

Tamoxifen therapy for breast cancer and endometrial cancer risk.

J. Cerhan, L. Ford, L. Bernstein, 1999, Journal of the National Cancer Institute.

prophylactic use of in the population.

N. Cook, L. Ford, C. Bosetti, 2014 .